Unlock instant, AI-driven research and patent intelligence for your innovation.

A class of intermediates for the preparation of anticancer drugs

A compound and solvent technology, which is applied in the field of intermediates for the preparation of drugs, can solve problems such as technical difficulties in anti-tumor drugs

Active Publication Date: 2021-11-05
CHENGDU HUAJIAN FUTURE TECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The technical problem solved by the present invention is to overcome the technical difficulties in the preparation of antitumor drugs in the prior art. The present invention provides a compound of the general formula shown in formula I and chemically acceptable salts:

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A class of intermediates for the preparation of anticancer drugs
  • A class of intermediates for the preparation of anticancer drugs
  • A class of intermediates for the preparation of anticancer drugs

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0032] In the preparation of compounds of the invention, it may be necessary to protect certain interfering functionalities (eg, primary or secondary amines) of intermediates. The requirements for such protecting groups vary depending on the nature of the particular functional group and the conditions of the preparation method. Suitable amino protecting groups include acetyl, trifluoroacetyl, tert-butoxycarbonyl (Boc), benzyloxycarbonyl (Cbz), 9-fluorenylmethyleneoxycarbonyl (Fmoc), and the like. Suitable hydroxy protecting groups include allyl, acetyl, silyl, benzyl, trityl, p-methoxybenzyl, and the like. Such protecting groups can be easily determined by those skilled in the art (for details, refer to Protective Groups in Organic Synthesis, John Wiley & Sons, New York, Third Edition, 1999).

[0033] The compounds of the present invention and the corresponding preparation methods are further explained and listed below through examples and preparations. It should be understo...

Embodiment 1

[0040]

[0041]Compound A (prepared according to WO2015059668 literature) weighed 3.34g in a round bottom flask, added 5mL ethylene glycol and 50mL dichloromethane, In(OTf) 3 Weigh 562mg into it, under the protection of nitrogen, stir at room temperature for 8h, TLC detects the reaction progress, after the reaction is completed, add 20mL of ethyl acetate, 20mL of water, continue to stir for 30min, separate the organic phase, and continue to use ethyl acetate for the water phase. Wash 3 times, combine the organic phases, dry overnight with anhydrous sodium sulfate, concentrate to obtain a semi-solid state substance, add tert-butyl methyl ether to the substance, continue stirring for 8 hours, and a solid precipitates, filter the solid, and wash 3 times with tert-butyl methyl ether, The compound 1 was obtained by air drying at 30°C, a total of 3.0 g, with a yield of 90.4%. 1 H NMR (600MHz, CDCl 3 ):δ7.08(s,1H),5.75(s,1H),5.04(s,1H),4.65(s,2H),4.21~4.17(m,2H),4.01~3.97(m,2H), ...

Embodiment 2

[0043]

[0044] Compound A (prepared according to WO2015059668 literature) weighed 3.34g in a round bottom flask, added 5mL ethylene glycol and 50mL dichloromethane, In(OTf) 3 Weigh 562mg into it, under the protection of nitrogen, stir at room temperature for 8h, TLC detects the reaction progress, after the reaction is completed, add 20mL of ethyl acetate, 20mL of water, continue to stir for 30min, separate the organic phase, and continue to use ethyl acetate for the water phase. Wash 3 times, combine the organic phases, dry overnight with anhydrous sodium sulfate, concentrate to obtain a semi-solid state substance, add tert-butyl methyl ether to the substance, continue stirring for 8 hours, and a solid precipitates, filter the solid, and wash 3 times with tert-butyl methyl ether, Compound 2 was obtained by blast drying at 30°C, a total of 3.2 g, with a yield of 92.5%. 1 H NMR (600MHz, CDCl 3 ):δ7.07(s,1H),5.53(s,1H),5.14(s,1H),4.75(s,2H),4.24~4.20(m,2H),3.98~3.92(m,2H), ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a raw material for synthesizing anticancer drugs and a key intermediate for synthesizing anticancer drugs. The invention also discloses a preparation method of the anticancer drug. The synthetic intermediate disclosed by the invention has low production cost, good physical and chemical properties, simple preparation and operation, and is very easy for industrialized production.

Description

Technical field: [0001] The invention specifically relates to a class of intermediates for the preparation of medicines and their application in the synthesis of antitumor medicines. Background technique: [0002] Fibroblast growth factor receptor 4 (FGFR4) inhibitors are potential antitumor drugs, and several drugs designed based on this target have entered the clinical research stage. Compounds with excellent activity include: FGF401, BLU554, BLU9931 and H3B6527. [0003] Novartis' FGFR4 selective inhibitor FGF401 can specifically target FGFR4 to treat malignant tumors such as liver cancer with its overexpression, and is currently recruiting patients in phase I / II clinical trials (NCT02325739). The FGFR4-specific inhibitor H3B6527 of H3 Biopharmaceuticals has strong anti-tumor activity on cells with FGF19 gene amplification, and has no bile acid-related adverse reactions in animal models of mice and monkeys. Recently, Blueprint Pharmaceuticals developed and reported a ne...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04A61K31/496A61P35/00
Inventor 张磊
Owner CHENGDU HUAJIAN FUTURE TECH CO LTD